Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Dr. Nadia K. WaheedChief Medical Officer | -14,83k | 122,63k | Vendita | 8,27 | 94,17k | -13,60% |
| 2026-05-28 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -394,70k | 0,00 | Other Disposition | - | 744,90k | -34,63% |
| 2026-05-26 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -21,16k | 173,48k | Vendita | 8,20 | 744,90k | -2,76% |
| 2026-05-26 | Dr. Peter K. KaiserChief Development Officer | -2,97k | 24,33k | Vendita | 8,20 | 89,81k | -3,20% |
| 2026-05-26 | Dr. Jeffrey S. HeierChief Scientific Officer | -3,02k | 24,75k | Vendita | 8,20 | 174,57k | -1,70% |
| 2026-05-26 | Mr. Sanjay NayakChief Strategy Officer | -1,86k | 15,24k | Vendita | 8,20 | 169,82k | -1,08% |
| 2026-04-09 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -394,70k | 0,00 | Other Disposition | - | 694,81k | -36,23% |
| 2026-02-23 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -20,06k | 166,06k | Vendita | 8,28 | 623,56k | -3,12% |
| 2026-02-23 | Dr. Jeffrey S. HeierChief Scientific Officer | -3,06k | 25,31k | Vendita | 8,28 | 177,59k | -1,69% |
| 2026-02-23 | Dr. Peter K. KaiserChief Development Officer | -2,81k | 23,27k | Vendita | 8,28 | 52,03k | -5,12% |
| 2026-02-23 | Mr. Sanjay NayakChief Strategy Officer | -1,76k | 14,56k | Vendita | 8,28 | 158,30k | -1,10% |
| 2026-02-20 | Dr. Nadia K. WaheedChief Medical Officer | -3,51k | 27,17k | Vendita | 7,74 | 61,78k | -5,38% |
| 2026-02-20 | Dr. Richard L. LindstromIndependent Director | 60,23k | 461,35k | Acquisto | 7,66 | 232,93k | 34,87% |
| 2026-02-12 | Mr. Donald NotmanCOO (Leave of Absence) | -11,45k | 103,47k | Vendita | 9,04 | 182,68k | -5,90% |
| 2026-02-12 | Mr. Sanjay NayakChief Strategy Officer | -10,35k | 93,55k | Vendita | 9,04 | 160,05k | -6,07% |
| 2026-02-12 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -124,88k | 1,13M | Vendita | 9,04 | 643,62k | -16,25% |
| 2026-02-12 | Dr. Nadia K. WaheedChief Medical Officer | -7,86k | 71,08k | Vendita | 9,04 | 65,29k | -10,75% |
| 2026-02-02 | Mr. Donald NotmanCOO (Leave of Absence) | -11,49k | 101,40k | Vendita | 8,54 - 9,14 | 155,79k | -6,87% |
| 2025-11-24 | Mr. Sanjay NayakChief Strategy Officer | -1,88k | 22,61k | Vendita | 12,04 | 133,40k | -1,39% |
| 2025-11-24 | Dr. Peter K. KaiserChief Development Officer | -3,01k | 36,14k | Vendita | 12,02 | 73,84k | -3,91% |
| 2025-11-24 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -19,53k | 235,14k | Vendita | 12,04 | 351,84k | -5,26% |
| 2025-11-26 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -49,75k | 0,00 | Other Disposition | - | 351,84k | -12,39% |
| 2025-11-24 | Dr. Jeffrey S. HeierChief Scientific Officer | -3,47k | 41,77k | Vendita | 12,04 | 128,35k | -2,63% |
| 2025-11-05 | Dr. Namrata SarojChief Business Officer | -25,87k | 277,79k | Vendita | 10,74 | 174,14k | -12,93% |
| 2025-10-08 | Mr. Todd D.C. AndermanChief Legal Officer & Corporate Secretary | -11,13k | 137,37k | Vendita | 12,34 | 87,57k | -11,28% |
| 2025-10-02 | Dr. Peter K. KaiserChief Development Officer | -9,65k | 106,47k | Vendita | 11,03 | 66,66k | -12,65% |
| 2025-10-02 | Dr. Jeffrey S. HeierChief Scientific Officer | -10,50k | 115,94k | Vendita | 11,04 | 121,63k | -7,95% |
| 2025-09-09 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -49,75k | 0,00 | Other Disposition | - | 300,12k | -14,22% |
| 2025-09-02 | Mr. Donald NotmanCOO (Leave of Absence) | -1,07k | 13,25k | Vendita | 12,43 | 126,84k | -0,83% |
| 2025-08-25 | Dr. Peter K. KaiserChief Development Officer | -3,01k | 36,25k | Vendita | 12,04 | 42,98k | -6,55% |
| 2025-08-25 | Mr. Sanjay NayakChief Strategy Officer | -1,89k | 22,70k | Vendita | 12,04 | 128,59k | -1,44% |
| 2025-08-25 | Dr. Jeffrey S. HeierChief Scientific Officer | -3,06k | 36,88k | Vendita | 12,04 | 98,80k | -3,01% |
| 2025-08-25 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -21,49k | 258,79k | Vendita | 12,04 | 300,12k | -6,68% |
| 2025-04-28 | Dr. Pravin U. DugelExecutive Chairman, President & CEO | -250,36k | 0,00 | Other Disposition | - | 250,36k | -50,00% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
